# HP1BP3

## Overview
HP1BP3, short for heterochromatin protein 1 binding protein 3, is a gene that encodes the nuclear protein heterochromatin protein 1 binding protein 3. This protein is primarily involved in the regulation of chromatin structure and plays a crucial role in maintaining the integrity of heterochromatin, which is essential for the proper regulation of gene transcription. Structurally, HP1BP3 is characterized by a glutamate-rich N-terminal domain, three globular domains similar to those found in histone H1, and a highly basic C-terminal domain. The protein also contains a unique DE region and a canonical HP1 binding motif, which are critical for its interaction with core histones and heterochromatin protein 1, respectively. The functional and structural attributes of HP1BP3 make it a significant player in chromatin dynamics, influencing various cellular processes including DNA repair, replication, and transcriptional regulation (Garfinkel2015HP1BP3).

## Structure
HP1BP3, or heterochromatin protein 1 binding protein 3, is characterized by a distinct structural organization reminiscent of the typical linker histone structure. It consists of a glutamate-rich N-terminal domain (NTD) predicted to be unstructured, followed by three globular domains (GD1, GD2, and GD3) that show high sequence homology to the globular domain of histone H1 family members. These globular domains are essential for the protein's function and structural integrity (Garfinkel2015HP1BP3). The C-terminal domain (CTD) of HP1BP3 is highly basic and unstructured, similar in amino acid composition to the gonadal subtypes H1.8 and H1.6, although the sequence itself is not identical (Garfinkel2015HP1BP3).

The protein also features a unique DE region, a 20 amino acid poly aspartate/glutamate tract, positioned between the third globular domain and the CTD, which plays a dual role in interacting with core histones and modulating DNA binding (Garfinkel2015HP1BP3). Additionally, HP1BP3 contains a canonical HP1 binding motif, PQVKL, located at residues 255-259 between the first two globular domains, essential for its interaction with heterochromatin protein 1 (Garfinkel2015HP1BP3).

The molecular structure of HP1BP3, including its primary, secondary, tertiary, or quaternary structures, has not been detailed in the provided contexts, nor have specific prominent folds or common post-translational modifications been described. Multiple splice variants of HP1BP3, notably HP1BP3a and HP1BP3b, result from the skipping of exon 2, leading to a product lacking the first 38 N-terminal amino acids (Garfinkel2015HP1BP3). These variants are expressed in both human and mouse cell lines and tissues, with HP1BP3a being the predominant form in most tissues.

## Function
HP1BP3, or heterochromatin protein 1 binding protein 3, is a nuclear protein that plays a significant role in the regulation of chromatin structure and cell cycle progression in human cells. It is involved in maintaining the integrity of heterochromatin, which is crucial for the proper regulation of gene transcription. HP1BP3 interacts with heterochromatin protein 1 (HP1), facilitating its role in chromatin organization. This interaction is mediated by a specific HP1 binding motif within HP1BP3, which is essential for its localization to heterochromatin (Garfinkel2015HP1BP3).

The protein exhibits three 'histone H1-like' domains that enable it to bind DNA and interact with chromatin similarly to histone H1. These interactions are crucial for maintaining the compact structure of heterochromatin, and disruptions in HP1BP3 can lead to a more open chromatin structure that is susceptible to enzymatic digestion (Dutta2014Profiling). Additionally, HP1BP3 influences cell proliferation by regulating the duration of the G1/S phase of the cell cycle, which impacts cell growth and clonogenicity (Dutta2014Profiling).

In organismal contexts, HP1BP3 has been shown to be vital for viability and growth. Knockout models in mice have demonstrated that the absence of HP1BP3 results in severe viability and growth issues, indicating its non-redundant functions in cellular health (Garfinkel2015HP1BP3). These findings underscore the importance of HP1BP3 in maintaining normal cellular and organismal functions.

## Clinical Significance
Mutations and alterations in the expression of the HP1BP3 gene have been linked to several clinical conditions and diseases. In the context of neurodegenerative diseases, reduced expression of HP1BP3 is associated with cognitive impairments in aging and Alzheimer's disease (AD). Studies have shown that knockdown of HP1BP3 in mice leads to decreased neuronal excitability, reduced synaptic plasticity, and impaired cognitive function, which are phenotypic features similar to those observed in aging and AD (Neuner2018Knockdown). Additionally, HP1BP3 has been identified as a significant modulator of cognitive aging, with its expression levels correlating with cognitive performance in both mice and humans. Lower or altered expression of this gene is linked to cognitive decline, suggesting its critical role in the transcriptional changes occurring during aging (Neuner2016Systems).

In cancer, HP1BP3 plays a role in tumor biology, particularly under hypoxic conditions common in tumor microenvironments. The gene is involved in chromatin organization and gene transcription regulation, influencing the repression of tumor suppressor genes and promoting tumor progression. Depletion of HP1BP3 in cancer cells leads to increased cell proliferation and changes in cell cycle dynamics, highlighting its potential as a therapeutic target in oncology (Dutta2014Quantitative).

Furthermore, HP1BP3 deficiency in mice has been shown to result in severe proportionate dwarfism, impacting growth and bone development through alterations in the endocrine IGF-1 pathway. This suggests a broader role of HP1BP3 in systemic physiological processes and developmental disorders (Garfinkel2015Proportionate).

## Interactions
HP1BP3 interacts with various proteins and nucleic acids, playing a significant role in chromatin architecture and dynamics. It binds to nucleosomal DNA, particularly at the entry and exit sites of nucleosomes, suggesting specific interaction points that are crucial for its function in chromatin organization (Garfinkel2015HP1BP3). This binding involves cooperation between its globular domain (GD) and the C-terminal domain (CTD), with the deletion of the CTD significantly reducing its affinity for chromatin (Garfinkel2015HP1BP3).

Additionally, HP1BP3 interacts with heterochromatin protein 1 (HP1), specifically through a canonical HP1 binding motif, PQVKL, located at residues 255-259. This interaction is essential for HP1BP3's enrichment in heterochromatin, as demonstrated by a mutation (V257E) that disrupts this binding and results in a significant loss of HP1BP3 localization to heterochromatin (Garfinkel2015HP1BP3). The interaction with HP1 is not entirely dependent on the PQVKL motif, indicating other possible interaction mechanisms that stabilize its chromatin association (Garfinkel2015HP1BP3).

These interactions underline the multifaceted role of HP1BP3 in chromatin dynamics, influencing gene transcription and nucleosome organization, thereby impacting various cellular processes including DNA repair, replication, and transcriptional regulation.


## References


[1. (Neuner2016Systems) Sarah M. Neuner, Benjamin P. Garfinkel, Lynda A. Wilmott, Bogna M. Ignatowska-Jankowska, Ami Citri, Joseph Orly, Lu Lu, Rupert W. Overall, Megan K. Mulligan, Gerd Kempermann, Robert W. Williams, Kristen M.S. OâConnell, and Catherine C. Kaczorowski. Systems genetics identifies hp1bp3 as a novel modulator of cognitive aging. Neurobiology of Aging, 46:58â67, October 2016. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2016.06.008, doi:10.1016/j.neurobiolaging.2016.06.008. (37 citations) 10.1016/j.neurobiolaging.2016.06.008](https://doi.org/10.1016/j.neurobiolaging.2016.06.008)

[2. (Neuner2018Knockdown) Sarah M. Neuner, Shengyuan Ding, and Catherine C. Kaczorowski. Knockdown of heterochromatin protein 1 binding protein 3 recapitulates phenotypic, cellular, and molecular features of aging. Aging Cell, December 2018. URL: http://dx.doi.org/10.1111/acel.12886, doi:10.1111/acel.12886. (14 citations) 10.1111/acel.12886](https://doi.org/10.1111/acel.12886)

[3. (Garfinkel2015Proportionate) Benjamin P. Garfinkel, Shiri Arad, Phuong T. Le, Michael Bustin, Clifford J. Rosen, Yankel Gabet, and Joseph Orly. Proportionate dwarfism in mice lacking heterochromatin protein 1 binding protein 3 (hp1bp3) is associated with alterations in the endocrine igf-1 pathway. Endocrinology, 156(12):4558â4570, September 2015. URL: http://dx.doi.org/10.1210/en.2015-1668, doi:10.1210/en.2015-1668. (17 citations) 10.1210/en.2015-1668](https://doi.org/10.1210/en.2015-1668)

[4. (Garfinkel2015HP1BP3) Benjamin P. Garfinkel, Naomi Melamed-Book, Eli Anuka, Michael Bustin, and Joseph Orly. Hp1bp3 is a novel histone h1 related protein with essential roles in viability and growth. Nucleic Acids Research, 43(4):2074â2090, February 2015. URL: http://dx.doi.org/10.1093/nar/gkv089, doi:10.1093/nar/gkv089. (24 citations) 10.1093/nar/gkv089](https://doi.org/10.1093/nar/gkv089)

[5. (Dutta2014Quantitative) Bamaprasad Dutta, Ren Yan, Sai Kiang Lim, James P. Tam, and Siu Kwan Sze. Quantitative profiling of chromatome dynamics reveals a novel role for hp1bp3 in hypoxia-induced oncogenesis. Molecular &amp; Cellular Proteomics, 13(12):3236â3249, December 2014. URL: http://dx.doi.org/10.1074/mcp.m114.038232, doi:10.1074/mcp.m114.038232. (0 citations) 10.1074/mcp.m114.038232](https://doi.org/10.1074/mcp.m114.038232)

[6. (Dutta2014Profiling) Bamaprasad Dutta, Yan Ren, Piliang Hao, Kae Hwan Sim, Esther Cheow, Sunil Adav, James P. Tam, and Siu Kwan Sze. Profiling of the chromatin-associated proteome identifies hp1bp3 as a novel regulator of cell cycle progression. Molecular &amp; Cellular Proteomics, 13(9):2183â2197, September 2014. URL: http://dx.doi.org/10.1074/mcp.m113.034975, doi:10.1074/mcp.m113.034975. (52 citations) 10.1074/mcp.m113.034975](https://doi.org/10.1074/mcp.m113.034975)